North America Contract Manufacturing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
北美合同制造市场，按产品（医药产品制造和医疗器械制造）、按最终用户（制药公司、生物技术公司、生物制药公司、医疗器械公司、原始设备制造商和研究机构）、按分销渠道（零售、直接招标和其他）划分 - 行业趋势和预测到 2030 年。
北美合同制造市场分析与洞察
北美合同制造市场受到以下因素的推动：技术进步和药品及管道产品成本效益的提高提高了其需求，而研发投资的增加也推动了市场增长。目前，发达国家和新兴国家的医疗保健支出都有所增加，这有望为制造商开发新的创新产品创造竞争优势。
合同制造是公司与制造商之间签订的合同，在指定时间内为公司生产一定数量的零部件或产品。生产的产品将贴上公司的标签或品牌。这称为自有品牌制造。如果是跨境生产，通常也被称为外包。制造商根据自己的设计、配方和规格提供服务，除非客户提供自己的设计、配方和规格。他们将为签约的任何人（甚至是竞争对手）生产这些产品。
推动合同制造市场增长的主要因素之一是北美医疗器械和制药行业的需求不断增长。多家公司为更好地诊断而进行的持续临床试验研究推动了市场扩张。市场还受到技术进步和成本效益的影响。然而，机密信息的风险和严格的法规可能会成为预测期内北美合同制造市场的制约因素
另一方面，专利到期、仿制药需求增加、医疗基础设施开支增加以及主要市场参与者的战略举措为市场增长提供了机遇。然而，知识产权风险以及越来越多的制药公司建立自己的制造部门可能会给北美合同制造市场带来挑战。
由于对即时诊断的需求不断增加，北美对合同制造的需求将会增加。各公司正在采取举措，逐步推动市场增长。
北美合同制造市场具有支持性，旨在减少医疗保健组织的制造工作量。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，北美合同制造市场将以 6.8% 的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015 - 2020) |
|
定量单位 |
收入（百万美元），定价（美元） |
|
涵盖的领域 |
按产品（医药产品制造和医疗器械制造）、按最终用户（制药公司、生物技术公司、生物制药公司、医疗器械公司、原始设备制造商和研究机构）、按分销渠道（零售、直接招标和其他） |
|
覆盖国家 |
美国、加拿大、墨西哥 |
|
涵盖的市场参与者 |
Aenova Group、Thermo Fisher Scientific Inc.、EVONIK INDUSTRIES AG、Lonza、Boehringer Ingelheim Biopharmaceuticals GmbH. 和 Catalent, Inc 等 |
北美合同制造动态
市场定义
国际市场上的合同制造是指一家公司安排另一家公司在其他国家生产其产品的情况；这也称为国际分包或国际外包。公司向制造商提供所有规格，如果适用，还提供生产过程所需的材料。这种类型的合同规定了制造商必须满足的有关产品质量、认证、数量、条件和交货日期等的要求。它还制定了由外包制造的公司或其客户提出的产品检验和测试指南。此外，它还概述了订单的修改，以及违约时的担保和赔偿。由于该过程本质上是将国外市场的生产外包给最终产品的私人品牌合作伙伴，因此有许多不同的公司和行业可以使用这种类型的合同。
驱动程序
- 为制造企业带来成本效益
耗时的制造和低效的生产以及管理是公共和私营部门组织的主要负担。它们对于应对复杂挑战也至关重要，因为单个组织在推动变革和有时所需的成果方面效率较低。合同制造公司将成为政府和私营部门不断增长的机会
随着对精确度更高、时间限制更少的合同制造的需求不断增长，推动了关键参与者采取战略举措。拥有合同制造可以免除投资于机械、材料和其他劳动力所需的间接费用，简化生产流程，并通过降低总体成本精简供应链。
然而，主要的市场参与者正在投入大量资金进行制造以满足最终用户的需求。合同制造参与者参与制定战略并通过降低这些参与者的生产成本来实施这些战略。为其他公司提供的合同制造服务还通过使用有效的劳动力、战略情报或生产周期所需的工作资源来确保资源的效率和最佳利用。
- 合同制造技术进步的兴起
由于医药行业的需求不断增长，一种新药的快速上市需要大量的生产投资。一些药物的配方复杂，批量生产时需要特定的设备和技术，因此先进的技术和技能是必不可少的。
人们正在考虑使用机器学习、大数据和人工智能等创新技术来开发药物或制造医疗器械，以实现快速制造。这些技术进步还有助于在短时间内实现大规模生产和可扩展性。
然而，制药公司通常会审核或监督其合同制造组织的生产和交付流程，以使用实时远程跟踪来监控制造过程。
机会
- 医疗基础设施建设费用不断增加
基础设施是实现这一基本目标的关键支柱，即促进所有患者的护理和福祉水平的提高，以及良好的医疗系统体验。与此同时，医疗系统和工作人员必须支持全民有效的健康促进、预防和自我护理。基础设施必须将医院作为急症和住院护理的中心，融入更广泛的医疗体系，并应促进优质患者体验、有效性、效率、及时性、安全性、公平性和可持续性这七个领域。基础设施包括建筑环境和支持要素：设备、通道、信息技术 (IT)、系统和流程、可持续性计划和工作人员。
然而，医疗保健基础设施建设的支出不断增长，正在推动预测期内北美合同制造市场的增长。
限制/挑战
- 设立生产基地的制药公司数量增加
大多数制药公司都在建设生产基地来生产药品，以降低成本。制造商更专注于引进先进技术和数字化流程。制药行业也面临着新的商业模式和人们对个性化药物和治疗更加关注的冲击。因此，对个性化护理的需求很高。职业概况也在发生变化：一些工作因自动化而消失，而全新的工作正在兴起。
因此，预测期内，越来越多的制药公司设立制造部门可能会对北美合同制造市场的增长构成挑战。
最新动态
- 2021年10月，勃林格殷格翰国际有限公司在奥地利维也纳启动了其最先进的生物制药生产设施大规模细胞培养（LSCC），投资额超过7亿欧元，这是该公司历史上最大的单笔投资
- 2023 年 3 月，赢创工业集团宣布将开设一家新的 GMP 工厂，生产用于先进药物输送应用的脂质。脂质启动设施位于该公司位于德国哈瑙的工厂，可为客户提供临床和小规模商业制造所需的脂质数量
北美合同制造市场细分
北美合同制造市场根据产品、最终用户和分销渠道分为三个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
产品
- 医疗器械制造
- 医药产品制造
根据产品，北美合同制造市场分为医疗器械制造和医药产品制造。
最终用户
- 制药公司
- 生物科技公司
- 生物制药公司
- 医疗器械公司
- 原始设备制造商
- 研究机构
根据最终用户，北美合同制造市场细分为原始设备制造商、医疗器械公司、制药公司、生物技术公司、生物制药公司和研究机构。
分销渠道
- 零售销售
- 直接招标
- 其他的
根据分销渠道，北美合同制造市场分为直接招标、零售和其他。
北美合同制造市场区域分析/见解
对北美合同制造市场进行了分析，并按上述产品、最终用户和分销渠道提供了市场规模洞察和趋势。
合同制造报告涵盖的国家包括美国、加拿大、墨西哥。
由于发展中地区的技术进步日益加快，美国预计将占据主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和北美合同制造市场份额分析
北美合同制造市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对北美合同制造市场的关注有关。
市场的一些参与者包括 Aenova Group、Thermo Fisher Scientific Inc.、EVONIK INDUSTRIES AG、Lonza、Boehringer Ingelheim Biopharmaceuticals GmbH. 和 Catalent, Inc 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA CONTRACT MANUFACTURING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC INITIATIVES:
5 REGULATORY FRAMEWORK
5.1 REGULATORY SCENARIO BY FDA
5.2 REGULATORY SCENARIO IN AUSTRALIA
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING
6.1.3 NORTH AMERICA PRESENCE AND CONNECTED NETWORK
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS
6.2.2 RISK OF CONFIDENTIAL INFORMATION
6.3 OPPORTUNITIES
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.4 CHALLENGES
6.4.1 INTELLECTUAL PROPERTY RISKS
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES
7 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING
7.2.1 TYPES OF PRODUCTS
7.2.1.1 TABLETS
7.2.1.2 CAPSULES
7.2.1.3 BIOLOGICS
7.2.1.4 SMALL MOLECULE
7.2.1.5 CELL & GENES MANUFACTURING
7.2.1.6 NUTRACEUTICALS
7.2.1.7 OTHERS
7.2.2 TYPE OF SERVICES
7.2.2.1 DRUG DEVELOPMENT SERVICES
7.2.2.2 TABLET MANUFACTURING SERVICES
7.2.2.3 BIOLOGICS API MANUFACTURING
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES
7.2.2.5 OTHERS
7.2.3 BY DOSAGE FORM
7.2.3.1 SOLID FORMULATIONS
7.2.3.2 LIQUID FORMULATIONS
7.2.3.2.1 INJECTABLE
7.2.3.2.2 SYRUPS
7.2.3.3 SEMI-SOLID FORMULATIONS
7.2.3.4 TOPICAL DRUG FORMULATIONS
7.2.3.5 OTHERS
7.3 MEDICAL DEVICE MANUFACTURING
7.3.1 TYPE OF DEVICES
7.3.1.1 SYRINGES AND NEEDLES
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES
7.3.1.4 DISPOSABLES
7.3.1.5 IVD DEVICES
7.3.1.6 CARDIOVASCULAR DEVICES
7.3.1.7 DIABETES CARE DEVICES
7.3.1.8 GENERAL SURGERY DEVICES
7.3.1.9 ORTHOPEDIC DEVICES
7.3.1.10 RESPIRATORY DEVICES
7.3.1.11 OPHTHALMIC DEVICES
7.3.1.12 DENTAL DEVICES
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES
7.3.1.14 LABORATORY EQUIPMENT
7.3.2 TYPE OF SERVICES
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT
7.3.2.2 DEVICE ASSEMBLY
7.3.2.3 REGULATORY ASSISTANCE
7.3.2.4 PACKAGING & LABELLING
7.3.2.5 STERILIZATION SERVICES
7.3.2.6 TRAINING AND VALIDATION
7.3.2.7 QUALITY ASSURANCE
7.3.2.8 OTHERS
7.3.3 BY DEVICE CLASS
7.3.3.1 CLASS I MEDICAL DEVICES
7.3.3.2 CLASS IIA MEDICAL DEVICES
7.3.3.3 CLASS IIB MEDICAL DEVICES
7.3.3.4 CLASS III MEDICAL DEVICES
8 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY END USER
8.1 OVERVIEW
8.2 PHARMACEUTICAL COMPANIES
8.3 BIOTECHNOLOGY COMPANIES
8.4 BIOPHARMA COMPANIES
8.5 MEDICAL DEVICES COMPANIES
8.6 ORIGINAL EQUIPMENT MANUFACTURER
8.7 RESEARCH INSTITUTES
9 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 RETAIL SALES
9.3 DIRECT TENDER
9.4 OTHERS
10 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY REGION
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
12 SWOT ANALYSIS
13 COMPANY PROFILE
13.1 AENOVA GROUP
13.1.1 COMPANY SNAPSHOT
13.1.2 COMPANY SHARE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 EVONIK INDUSTRIES AG
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 LONZA
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 ABBVIE INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 ALMAC GROUP
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 AVID BIOSERVICES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 BAXTER
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.1 CATALENT, INC
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 FAMAR HEALTH CARE SERVICES
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 JUBILANT PHARMA LIMITED
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 KIMBALL INTERNATIONAL
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 MERCK KGAA
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 NIPR0
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 PFIZER INC
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENT
13.17 RECIPHARM AB.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENT
13.18 SIEGFRIED HOLDING AG
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 TE CONNECTIVITY
13.20.1 COMPANY SNAPSHOT
13.20.2 REVENUE ANALYSIS
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENT
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT)
TABLE 29 NORTH AMERICA NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP)
TABLE 30 NORTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 36 NORTH AMERICA TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 37 NORTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 U.S. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 U.S. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 U.S. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 U.S. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 45 U.S. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 46 U.S. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 47 U.S. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 U.S. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 U.S. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 U.S. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 U.S. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 52 U.S. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 53 U.S. TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 U.S. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 U.S. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 56 U.S. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 57 CANADA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 CANADA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 CANADA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 CANADA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 61 CANADA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 62 CANADA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CANADA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 CANADA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 CANADA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 CANADA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 CANADA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 68 CANADA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 69 CANADA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 70 CANADA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 CANADA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 72 CANADA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 73 MEXICO CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 MEXICO PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 MEXICO TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 MEXICO TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 77 MEXICO TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 78 MEXICO BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 MEXICO BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 MEXICO LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 MEXICO MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 MEXICO TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 MEXICO TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 84 MEXICO TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 85 MEXICO TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 MEXICO BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 MEXICO CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 MEXICO CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA CONTRACT MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CONTRACT MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA CONTRACT MANUFACTURING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CONTRACT MANUFACTURING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CONTRACT MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA CONTRACT MANUFACTURING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA CONTRACT MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA CONTRACT MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 RISING TECHNOLOGICAL ADVANCEMENTS AND COST-EFFECTIVENESS OF PHARMACEUTICAL AND MEDICAL PRODUCTS ARE EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA CONTRACT MANUFACTURING MARKET
FIGURE 12 THE PHARMACEUTICAL PRODUCTS MANUFACTURING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CONTRACT MANUFACTURING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CONTRACT MANUFACTURING MARKET
FIGURE 14 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2022
FIGURE 15 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY END USER, 2022
FIGURE 19 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 22 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 23 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 26 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: SNAPSHOT (2022)
FIGURE 27 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY COUNTRY (2022)
FIGURE 28 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY PRODUCT (2023-2030)
FIGURE 31 NORTH AMERICA CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
